Role of cyclic AMP response element binding protein in human leukemias.
about
TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformationControl of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic targetExpression profile of CREB knockdown in myeloid leukemia cells.Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein.Analysis of promoters and CREB/AP-1 binding sites of the human TMEM174 geneCyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer.Transmembrane protease serine 4 promotes thyroid cancer proliferation via CREB phosphorylation.HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.Small molecule screen for inhibitors of expression from canonical CREB response element-containing promotersCREB is a critical regulator of normal hematopoiesis and leukemogenesis.Potential role of CREB as a prognostic marker in acute myeloid leukemia.Review: genetic models of acute myeloid leukaemia.CREB: A Key Regulator of Normal and Neoplastic Hematopoiesis.Hypoxia-mediated alterations and their role in the HER-2/neuregulated CREB status and localization.Anti-apoptotic effect of Tax: an NF-κB path or a CREB way?Targeting novel signaling pathways for resistant acute myeloid leukemia.Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells.Essential role for cyclic-AMP responsive element binding protein 1 (CREB) in the survival of acute lymphoblastic leukemia.Replication factor C3 is a CREB target gene that regulates cell cycle progression through the modulation of chromatin loading of PCNA.Fragment screening and druggability assessment for the CBP/p300 KIX domain through protein-observed 19F NMR spectroscopy.Regulation of CREB activation by p38 mitogen activated protein kinase during human primary erythroblast differentiation.The impact of Mir-9 regulation in normal and malignant hematopoiesis.
P2860
Q24674168-BAC5726D-7A55-4A25-91B0-7E8D1BD6FFFCQ28070887-C0350CCA-B40F-48BD-862D-DFDEF17886BEQ33370413-3654BEDB-70DD-4627-9FFB-6D6596A8452AQ34064620-1115DE20-B03A-4C27-8F66-365D33EEAEC1Q34384645-EE5BB1F6-3309-4BE9-A867-CBE26B4D3A8BQ34684234-C821BDE2-176E-47CE-ABB1-E713F4352527Q34915132-EED3B3DE-4151-4031-8575-F4DC98D6B2BAQ35114430-9CE33F32-06DF-44F3-80C0-BE41BBCFB62BQ35912981-9DDAC2DD-B367-40A5-A902-65BC8A70442CQ36407217-9B8B456F-2398-4161-8FDC-FC7D946F3562Q36895824-2DDB4285-449B-4A1A-8632-5D07681F9B17Q37080843-EFA67DC1-1500-4111-9FBD-17EDE8B93092Q37423779-726D6627-2B12-41B6-B11C-96F5472ABC05Q37588413-8D81DF23-0509-40AC-B97A-23764840A46AQ37945234-405181DA-216D-4F8A-A7C8-5CD358617345Q38297507-80847478-B272-41C6-BC0F-15744604B4E8Q38769308-C342C7E2-A584-4439-9E44-0465654AA98BQ38871097-FE99A177-4BC2-4653-A0C3-DA60CB763BACQ38925416-A139CBE2-7214-493B-BED0-97CEA43DFD8FQ39043214-96D84C51-A4EE-440A-A8B0-C535C246E940Q43263194-DB3526DD-4D27-44DE-856B-B644A5FEE4B5Q54941919-BEF8EB6E-491E-4AF3-BB0D-C6B6B9D15442
P2860
Role of cyclic AMP response element binding protein in human leukemias.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Role of cyclic AMP response element binding protein in human leukemias.
@ast
Role of cyclic AMP response element binding protein in human leukemias.
@en
type
label
Role of cyclic AMP response element binding protein in human leukemias.
@ast
Role of cyclic AMP response element binding protein in human leukemias.
@en
prefLabel
Role of cyclic AMP response element binding protein in human leukemias.
@ast
Role of cyclic AMP response element binding protein in human leukemias.
@en
P2093
P356
P1433
P1476
Role of cyclic AMP response element binding protein in human leukemias.
@en
P2093
Deepa B Shankar
Jerry C Cheng
Kathleen M Sakamoto
P2860
P304
P356
10.1002/CNCR.21401
P407
P577
2005-11-01T00:00:00Z